The FDA granted orphan designation to Sanofi US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Discover th ...

The pharma signed an agreement handing PE firm CD&R a 50% stake in its Capella unit. Elsewhere, Gilead and Ultragenyx secured ...

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

(Reuters) - Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing in partnership with Sanofi.

On an adjusted basis, Biogen expects 2025 profit between $15.25 and $16.25 per share. It earned $16.47 in 2024 and analysts ...

News for Sanofi India Ltd. CD&R Acquires 26% Stake in Sanofi Consumer Healthcare India - Rs 2,983 Cr Open Offer Global investment firm CD&R has announced an open offer to acquire a 26% stake ...

Sales of anti-inflammatory drug Dupixent rose 15% to $3.7 billion. The French partner, Sanofi, records Dupixent's sales and the profits are split equally between the companies. Its skin cancer drug, ...

As media companies continue to overhaul the traditional “spray-and-pray” nature of television advertising, AMC Networks has launched a new ad-tech tool focused on consumer outcomes.

800 crore (US$ 96.28 million) in current financial year, with further initiatives in pipeline. The Indian consumer durables market is broadly segregated into urban and rural markets and is attracting ...

Sanofi has initiated the process of selling its consumer health unit, with France’s PAI Partners and the Abu Dhabi Investment Authority (ADIA) emerging as key players in the bidding. The French ...